167 related articles for article (PubMed ID: 9129922)
1. The impact of prostate-specific antigen, its density and the Gleason score in the prediction of extracapsular disease in prostate carcinoma.
Akdaş A; Tarcan T; Türkeri L; Biren T; Küllü S; Ilker Y
Eur Urol; 1997; 31(3):311-6. PubMed ID: 9129922
[TBL] [Abstract][Full Text] [Related]
2. The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer.
Narayan P; Gajendran V; Taylor SP; Tewari A; Presti JC; Leidich R; Lo R; Palmer K; Shinohara K; Spaulding JT
Urology; 1995 Aug; 46(2):205-12. PubMed ID: 7542823
[TBL] [Abstract][Full Text] [Related]
3. Preoperative prediction of extracapsular tumor extension at radical retropubic prostatectomy in Taiwanese patients with T1c prostate cancer.
Ou YC; Chen JT; Yang CR; Cheng CL; Ho HC; Kao YL; Ko JL; Hsieh YS
Jpn J Clin Oncol; 2002 May; 32(5):172-6. PubMed ID: 12110644
[TBL] [Abstract][Full Text] [Related]
4. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
[TBL] [Abstract][Full Text] [Related]
5. Important preoperative prognostic factors for extracapsular extension, seminal vesicle invasion and lymph node involvement in cases with radical retropubic prostatectomy.
Ozgür A; Onol FF; Türkeri LN
Int Urol Nephrol; 2004; 36(3):369-73. PubMed ID: 15783108
[TBL] [Abstract][Full Text] [Related]
6. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
[TBL] [Abstract][Full Text] [Related]
7. Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy.
Ravery V; Boccon-Gibod LA; Dauge-Geffroy MC; Billebaud T; Delmas V; Meulemans A; Toublanc M; Boccon-Gibod L
Urology; 1994 Sep; 44(3):371-6. PubMed ID: 7521093
[TBL] [Abstract][Full Text] [Related]
8. Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens.
Lima NG; Soares Dde F; Rhoden EL
Clinics (Sao Paulo); 2013 Jun; 68(6):820-4. PubMed ID: 23778496
[TBL] [Abstract][Full Text] [Related]
9. Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer.
Ravery V; Chastang C; Toublanc M; Boccon-Gibod L; Delmas V; Boccon-Gibod L
Eur Urol; 2000 Apr; 37(4):449-55. PubMed ID: 10765076
[TBL] [Abstract][Full Text] [Related]
10. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
[TBL] [Abstract][Full Text] [Related]
11. Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?
Kim SJ; Jeong TY; Yoo DS; Park J; Cho S; Kang SH; Lee SH; Jeon SH; Lee TY; Park SY
Yonsei Med J; 2015 Nov; 56(6):1492-6. PubMed ID: 26446628
[TBL] [Abstract][Full Text] [Related]
12. Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng./ml.
Zlotta AR; Djavan B; Petein M; Susani M; Marberger M; Schulman CC
J Urol; 1998 Dec; 160(6 Pt 1):2089-95. PubMed ID: 9817330
[TBL] [Abstract][Full Text] [Related]
13. Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels.
Schmid HP; Ravery V; Billebaud T; Toublanc M; Boccon-Gibod LA; Hermieu JF; Delmas V; Boccon-Gibod L
Urology; 1996 May; 47(5):699-703. PubMed ID: 8650868
[TBL] [Abstract][Full Text] [Related]
14. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
Graefen M; Noldus J; Pichlmeier U; Haese A; Hammerer P; Fernandez S; Conrad S; Henke R; Huland E; Huland H
Eur Urol; 1999; 36(1):21-30. PubMed ID: 10364651
[TBL] [Abstract][Full Text] [Related]
15. Detection rates of nonpalpable prostate cancer in Korean men with prostate-specific antigen levels between 2.5 and 4.0 ng/mL.
Kim HS; Jeon SS; Choi JD; Kim W; Han DH; Jeong BC; Seo SI; Lee KS; Lee SW; Lee HM; Choi HY
Urology; 2010 Oct; 76(4):919-22. PubMed ID: 20303152
[TBL] [Abstract][Full Text] [Related]
16. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC
Cancer; 2003 Dec; 98(11):2344-50. PubMed ID: 14635068
[TBL] [Abstract][Full Text] [Related]
17. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.
Flood TA; Schieda N; Keefe DT; Breau RH; Morash C; Hogan K; Belanger EC; Mai KT; Robertson SJ
Virchows Arch; 2016 Sep; 469(3):313-9. PubMed ID: 27394432
[TBL] [Abstract][Full Text] [Related]
18. Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?
Jin BS; Kang SH; Kim DY; Oh HG; Kim CI; Moon GH; Kwon TG; Park JS
Korean J Urol; 2015 Sep; 56(9):624-9. PubMed ID: 26366274
[TBL] [Abstract][Full Text] [Related]
19. Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density.
Allan RW; Sanderson H; Epstein JI
J Urol; 2003 Aug; 170(2 Pt 1):370-2. PubMed ID: 12853777
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels.
Roehrborn CG; Pickens GJ; Sanders JS
Urology; 1996 Mar; 47(3):347-52. PubMed ID: 8633400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
